Scott Suttell
- STERIS Corp. (NYSE: STE) and Synergy Health are still awaiting word on their challenge to the U.S. Federal Trade Commission’s blocking of their proposed $1.9 billion merger, and they’ve pushed back yet again shareholder votes on the combination. Mentor-based STERIS announced in a news release on Monday, Sept. 24, that it has rescheduled the vote of its shareholders on deal to Oct. 2 from Sept. 24. United Kingdom-based Synergy Health also has rescheduled its shareholder meeting for
↧